TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -51.24%1.69B | 4.71%7.19B | 46.96%3.47B | 48.02%6.87B | -16.23%2.36B | -23.32%4.64B | 8.50%2.82B | 36.75%6.05B | 40.73%2.6B | 10.02%4.43B |
Operating income | -51.24%1.69B | 4.71%7.19B | 46.96%3.47B | 48.02%6.87B | -16.23%2.36B | -23.32%4.64B | 8.50%2.82B | 36.75%6.05B | 40.73%2.6B | 10.02%4.43B |
Cost of sales | 48.40%-1.67B | -2.07%-6.73B | -43.82%-3.24B | -55.77%-6.6B | 8.05%-2.25B | 22.51%-4.24B | -5.54%-2.45B | -33.84%-5.47B | -32.15%-2.32B | -12.67%-4.08B |
Operating expenses | 48.40%-1.67B | -2.07%-6.73B | -43.82%-3.24B | -55.77%-6.6B | 8.05%-2.25B | 22.51%-4.24B | -5.54%-2.45B | -33.84%-5.47B | -32.15%-2.32B | -12.67%-4.08B |
Gross profit | -90.60%21.97M | 68.84%458M | 110.66%233.78M | -33.02%271.26M | -70.13%110.98M | -30.87%405M | 33.10%371.52M | 71.62%585.85M | 205.85%279.14M | -14.13%341.37M |
Selling expenses | 35.44%-38.92M | -25.91%-100.64M | -5,087.61%-60.28M | 44.06%-79.93M | 98.18%-1.16M | -5.13%-142.89M | -0.96%-63.76M | -60.68%-135.91M | -49.15%-63.15M | -9.21%-84.58M |
Administrative expenses | 11.29%-102.76M | -5.47%-279.05M | -44.21%-115.84M | -91.24%-264.58M | 40.80%-80.33M | 68.59%-138.35M | 26.26%-135.7M | -7.58%-440.5M | -6.48%-184.01M | -8.43%-409.46M |
Impairment and provision | -509.57%-49.04M | 119.69%12.65M | 2,528.60%11.97M | -425.17%-64.25M | 94.71%-493K | 154.43%19.76M | -48,921.05%-9.31M | 23.42%-36.3M | ---19K | 48.20%-47.4M |
-Impairment of property, machinery and equipment | ---48.77M | ---- | ---- | ---43.04M | ---- | ---- | ---- | ---- | ---- | 67.74%-15.17M |
-Other impairment is provision | -102.26%-271K | 159.64%12.65M | 2,528.60%11.97M | -207.36%-21.21M | 94.71%-493K | 154.43%19.76M | -48,921.05%-9.31M | -12.61%-36.3M | ---19K | 27.55%-32.24M |
Special items of operating profit | -18.45%94.35M | 40.44%137.28M | 161.55%115.69M | 37.68%97.75M | -30.05%44.23M | 9.42%71M | -4.49%63.24M | 306.27%64.88M | 98.78%66.21M | -70.29%15.97M |
Operating profit | -140.14%-74.4M | 674.21%228.25M | 153.08%185.33M | -118.53%-39.75M | -67.60%73.23M | 464.22%214.51M | 130.21%225.98M | 120.65%38.02M | 208.36%98.16M | -93.25%-184.11M |
Financing cost | 12.40%-31.36M | 9.74%-71.12M | 20.44%-35.79M | 23.00%-78.79M | 25.96%-44.99M | 13.83%-102.33M | 7.57%-60.76M | 3.56%-118.75M | -12.43%-65.74M | 9.47%-123.13M |
Share of profits of associates | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 88.20%-157K | 74.18%-157K | 8.97%-1.33M |
Special items of earning before tax | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -1,429.94%-68.59M | ---4.48M |
Earning before tax | -170.72%-105.75M | 232.55%157.13M | 429.55%149.53M | -205.67%-118.54M | -82.91%28.24M | 238.69%112.18M | 554.86%165.22M | 74.16%-80.89M | 76.44%-36.32M | -34.50%-313.05M |
Tax | 118.02%4.04M | 4.47%-15.46M | -11,264.47%-22.39M | 65.53%-16.19M | 99.56%-197K | -55.12%-46.96M | -598.76%-44.57M | 26.71%-30.27M | 72.21%-6.38M | -439.79%-41.31M |
After-tax profit from continuing operations | -180.00%-101.72M | 205.15%141.67M | 353.43%127.15M | -306.57%-134.73M | -76.76%28.04M | 158.67%65.22M | 382.53%120.65M | 68.63%-111.16M | 75.89%-42.7M | -60.64%-354.36M |
After-tax profit from non-continuing business | ---- | ---- | ---- | 425.79%1.25B | --105.68M | 378.30%237.13M | ---- | ---85.21M | ---- | ---- |
Earning after tax | -180.00%-101.72M | -87.26%141.67M | -4.92%127.15M | 267.81%1.11B | 10.84%133.72M | 253.97%302.35M | 382.53%120.65M | 44.59%-196.37M | 75.89%-42.7M | -60.64%-354.36M |
Minority profit | -102.10%-572K | -80.79%29.76M | -58.71%27.24M | 41.96%154.93M | 11.22%65.96M | 466.00%109.13M | 402.99%59.31M | 1,600.26%19.28M | 66.19%11.79M | -37.52%1.13M |
Profit attributable to shareholders | -201.24%-101.15M | -88.31%111.91M | 47.44%99.91M | 395.37%957.16M | 10.47%67.76M | 189.60%193.22M | 212.56%61.34M | 39.34%-215.65M | 70.42%-54.49M | -59.84%-355.49M |
Basic earnings per share | -201.00%-0.0304 | -88.30%0.0337 | 47.55%0.0301 | 393.15%0.288 | 9.68%0.0204 | 185.63%0.0584 | 208.77%0.0186 | 38.39%-0.0682 | 70.21%-0.0171 | -59.97%-0.1107 |
Diluted earnings per share | -201.00%-0.0304 | -88.30%0.0337 | 47.55%0.0301 | 393.15%0.288 | 9.68%0.0204 | 185.63%0.0584 | 208.77%0.0186 | 38.39%-0.0682 | 70.21%-0.0171 | -59.97%-0.1107 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS and HKAS | IAS and HKAS | IAS and HKAS | IAS and HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.